We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
376
DELISTED
PROS Holdings
PRO
| $4.37M | 0.06% |
+69,090
| New | +$3.64M |
|
|
ACOR
377
DELISTED
Acorda Therapeutics
ACOR
| $4.31M | 0.06% |
4,686
-626
| -12% | -$769K |
|
378
A10 Networks
ATEN
$2.47B
| $4.3M | 0.06% |
631,188
+26,600
| +4% | +$174K |
|
379
Harmonic Inc
HLIT
$1.21B
| $4.27M | 0.06% |
769,475
+98,550
| +15% | +$547K |
|
380
Verizon
VZ
$194B
| $4.25M | 0.06% |
+74,340
| New | +$4.28M |
|
381
Silicon Laboratories
SLAB
$7.15B
| $4.24M | 0.06% |
40,980
-25,230
| -38% | -$2.43M |
|
382
Rambus
RMBS
$10.4B
| $4.21M | 0.06% |
349,536
-115,602
| -25% | -$1.32M |
|
|
DOOR
383
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $4.19M | 0.06% |
79,518
+23,498
| +42% | +$1.22M |
|
384
Perrigo
PRGO
$1.4B
| $4.08M | 0.06% |
85,570
+4,380
| +5% | +$209K |
|
385
Veeco
VECO
$3.15B
| $4.07M | 0.06% |
333,047
+8,365
| +3% | +$101K |
|
|
TIVO
386
DELISTED
Tivo Inc
TIVO
| $4.07M | 0.06% |
551,782
+444,410
| +414% | +$3.57M |
|
387
Ally Financial
ALLY
$13.1B
| $4.03M | 0.06% |
129,890
-910
| -0.7% | -$26.9K |
|
388
Air Products & Chemicals
APD
$66.3B
| $4.03M | 0.06% |
17,780
+13,010
| +273% | +$2.69M |
|
389
Travere Therapeutics
TVTX
$5.33B
| $3.98M | 0.06% |
198,035
+45,100
| +29% | +$890K |
|
390
Employers Holdings
EIG
$908M
| $3.96M | 0.05% |
93,766
+17,210
| +22% | +$720K |
|
|
GHDX
391
DELISTED
Genomic Health, Inc.
GHDX
| $3.94M | 0.05% |
67,728
-76,409
| -53% | -$4.53M |
|
392
Regions Financial
RF
$26.3B
| $3.92M | 0.05% |
262,118
-200
| -0.1% | -$2.95K |
|
393
BancFirst
BANF
$3.92B
| $3.89M | 0.05% |
69,962
+13,400
| +24% | +$744K |
|
394
ArcBest
ARCB
$3.44B
| $3.84M | 0.05% |
136,737
-106,864
| -44% | -$3.11M |
|
395
O'Reilly Automotive
ORLY
$72.4B
| $3.84M | 0.05% |
+156,075
| New | +$3.95M |
|
396
BJs Wholesale Club
BJ
$11.9B
| $3.84M | 0.05% |
145,530
-55,325
| -28% | -$1.47M |
|
397
JPMorgan Chase
JPM
$939B
| $3.81M | 0.05% |
34,094
-135,686
| -80% | -$15M |
|
398
Frontdoor
FTDR
$5.02B
| $3.77M | 0.05% |
+86,681
| New | +$3.33M |
|
399
Adient
ADNT
$1.6B
| $3.76M | 0.05% |
155,018
+17,918
| +13% | +$369K |
|
400
Arlo Technologies
ARLO
$1.4B
| $3.73M | 0.05% |
930,449
+799,636
| +611% | +$3.14M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.